Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)
China · Delayed Price · Currency is CNY 51.17
-0.61 (-1.18%)
Nov 6, 2026, 2:45 PM CST
SHE:300841 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 258.05 | 219.9 | 398.65 | 509.22 | 598.07 | 829.48 |
Depreciation & Amortization | 73.51 | 73.51 | 65.23 | 51.46 | 32.57 | 16.53 |
Other Amortization | 15.01 | 15.01 | 9.46 | 10.31 | 8.38 | 5.29 |
Loss (Gain) From Sale of Assets | 0.01 | 0.01 | 1.79 | 0.48 | 0.74 | 0.11 |
Asset Writedown & Restructuring Costs | 0.12 | 0.12 | 0.02 | - | - | - |
Loss (Gain) From Sale of Investments | -1.86 | -1.86 | 58.83 | 31.25 | -56.9 | -273.98 |
Provision & Write-off of Bad Debts | 11.05 | 11.05 | 15.16 | 8.6 | 34.09 | 8.35 |
Other Operating Activities | 93.57 | 12.19 | 20.22 | 7.74 | 13.07 | 2.17 |
Change in Accounts Receivable | 64.31 | 64.31 | 102.45 | -113.84 | -448.91 | -535.23 |
Change in Inventory | 27.99 | 27.99 | -4.98 | -21.52 | -56.86 | -57.53 |
Change in Accounts Payable | -37.73 | -37.73 | -90.03 | 95.7 | 61.35 | 124.72 |
Change in Other Net Operating Assets | - | - | - | -3.96 | 3.12 | 12.27 |
Operating Cash Flow | 499.25 | 379.71 | 572.24 | 573.98 | 194.99 | 130.33 |
Operating Cash Flow Growth | 5.54% | -33.65% | -0.30% | 194.37% | 49.62% | -64.73% |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Capital Expenditures | -52.23 | -70.79 | -144.3 | -157.27 | -419.23 | -314.94 |
Sale of Property, Plant & Equipment | 0.05 | 0.07 | 0.28 | 0.04 | 0 | 0.01 |
Investment in Securities | -614.79 | 208.32 | -198.88 | -6.5 | 6.25 | 108.75 |
Other Investing Activities | 10.85 | 9.75 | 1.04 | 0.35 | 0.52 | 4.65 |
Investing Cash Flow | -673.15 | 147.35 | -341.87 | -163.39 | -412.46 | -201.53 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Short-Term Debt Issued | - | 179.79 | 237.78 | 221.75 | - | - |
Long-Term Debt Issued | - | - | - | - | 155.93 | - |
Total Debt Issued | 30 | 179.79 | 237.78 | 221.75 | 155.93 | - |
Short-Term Debt Repaid | - | -226.78 | -241.75 | -156.93 | - | - |
Long-Term Debt Repaid | - | - | - | -0.31 | -30 | - |
Lease Payments | - | - | - | -0.31 | - | - |
Total Debt Repaid | -179.79 | -226.78 | -241.75 | -157.24 | -30 | - |
Net Debt Issued (Repaid) | -149.79 | -46.99 | -3.97 | 64.52 | 125.93 | - |
Issuance of Common Stock | - | - | - | - | 5.17 | - |
Repurchase of Common Stock | - | - | -200 | - | - | - |
Common Dividends Paid | -66.23 | -136.43 | -267.83 | -71.63 | -136.82 | -90 |
Other Financing Activities | -0.44 | - | - | - | -67.84 | -57.4 |
Financing Cash Flow | -216.47 | -183.42 | -471.79 | -7.12 | -73.56 | -147.4 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Foreign Exchange Rate Adjustments | -0.05 | 0.04 | 1.77 | -0.07 | 0.11 | -0.01 |
Net Cash Flow | -390.42 | 343.68 | -239.65 | 403.41 | -290.92 | -218.61 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Free Cash Flow | 447.01 | 308.92 | 427.94 | 416.71 | -224.24 | -184.61 |
Free Cash Flow Growth | 18.49% | -27.81% | 2.70% | - | - | - |
Free Cash Flow Margin | 36.96% | 26.52% | 29.89% | 26.42% | -15.50% | -14.28% |
Free Cash Flow Per Share | 3.44 | 2.38 | 3.25 | 3.12 | -1.67 | -1.37 |
Levered Free Cash Flow | 298.24 | 203.84 | 278.84 | 140.63 | -311.18 | -314.21 |
Unlevered Free Cash Flow | 298.99 | 206.14 | 282.2 | 143.63 | -309.19 | -314.17 |
Free Cash Flow After Leases | 447.01 | 308.92 | 427.94 | 416.4 | -224.24 | -184.61 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash Income Tax Paid | 129.91 | 71.75 | 144.18 | 105.34 | 143.61 | 118.61 |
Change in Working Capital | 49.78 | 49.78 | 2.87 | -45.08 | -435.02 | -457.63 |